In one paragraphArticle in RSC medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Berehe Solomon GirmayInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0000-0002-9332-6469 Sileshi Abera AyeleInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0000-0002-2647-0874 Syed Azeem AbbasInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0009-0007-0575-0432 Su San JangInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0009-0007-7559-8202 Eunhye JungInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0009-0008-5028-9021 Jin Soo ShinInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0009-0007-0742-4032 Soo Bong HanInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0000-0002-7831-1832 Hyejin KimInfectious Diseases Therapeutic Research Center, Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology Daejeon 34114 Republic of Korea sbhan@krict.re.kr hjinkim@krict.re.kr.ORCID https://orcid.org/0000-0002-6797-2360 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The Zika virus (ZIKV), a significant public health threat, is transmitted by
Identifiers
PMID39157190
PMCPMC11325340
What OpenQuestion holds
Textmetadata
Read underepoch 390